EB13

ICD-11 MMS 2026-01

Stevens-Johnson syndrome or toxic epidermal necrolysis

Description

A spectrum of severe and life-threatening hypersensitivity disorders affecting skin and mucous membranes, most commonly precipitated by an idiosyncratic reaction to medication. Stevens-Johnson syndrome (SJS) always involves mucosal surfaces but the skin involvement is limited by definition to <10% body surface area (BSA). Toxic epidermal necrolysis (TEN) may sometimes spare mucous membranes but skin involvement is by definition >30% BSA. An intermediate form is recognised in which mucosal involvement is accompanied by skin involvement of 10-30% BSA (SJS-TEN overlap syndrome). All forms result in extensive sloughing and ulceration and carry a significant risk of fatal outcome.

Index terms

  • Stevens-Johnson syndrome or toxic epidermal necrolysis
  • SJS/TEN - [Stevens-Johnson syndrome and toxic epidermal necrolysis]

Exclusions from above levels

  • 1B72.0 – Bullous impetigo of the napkin area
  • 1F23.12 – Napkin candidosis
  • EH71 – Dermatoses precipitated by drug therapy
Show allHide
  • EH76 – Dermatoses associated with specific classes of medication

Child codes

  • EB13.0 – Stevens-Johnson syndrome
  • EB13.1 – Toxic epidermal necrolysis
  • EB13.2 – Stevens-Johnson and toxic epidermal necrolysis overlap syndrome

Foundation children elsewhere

  • EH63 – Stevens-Johnson syndrome or toxic epidermal necrolysis due to drug

Sibling codes

  • EB10 – Diffuse inflammatory erythemas
  • EB11 – Annular erythema
  • EB12 – Erythema multiforme
  • EB30 – Eosinophilic cellulitis
  • EB31 – Erythema nodosum

Foundation entity

Stevens-Johnson syndrome or toxic epidermal necrolysis – http://id.who.int/icd/entity/195467267

Part of: 14: Diseases of the skin